Cargando…
Assessment of whole body MRI and sestamibi technetium-99m bone marrow scan in prediction of multiple myeloma disease progression and outcome: a prospective comparative study
OBJECTIVES: This study aims primarily to determine whether whole body MRI (WB-MRI) and Sestamibi Technetium-99m-bone marrow (MIBI) scans in the same patients produce the same estimate of disease load and location, and secondly, to study possible association between the bone disease detected by these...
Autores principales: | Khalafallah, Alhossain A, Snarski, Andrew, Heng, Robert, Hughes, Ryan, Renu, Shamsunnaher, Arm, Jameen, Dutchke, Richard, Robertson, Iain K, To, Luen B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549203/ https://www.ncbi.nlm.nih.gov/pubmed/23315438 http://dx.doi.org/10.1136/bmjopen-2012-002025 |
Ejemplares similares
-
PERCEPT myeloma: a protocol for a pilot randomised controlled trial of exercise prehabilitation before and during autologous stem cell transplantation in patients with multiple myeloma
por: McCourt, Orla, et al.
Publicado: (2020) -
Quantifying intervals to diagnosis in myeloma: a systematic review and meta-analysis
por: Koshiaris, Constantinos, et al.
Publicado: (2018) -
Effect of bortezomib on the treatment of multiple myeloma: a systematic review protocol
por: Cantadori, Lucas Oliveira, et al.
Publicado: (2022) -
Frailty-adjusted therapy in Transplant Non-Eligible patients with newly diagnosed Multiple Myeloma (FiTNEss (UK-MRA Myeloma XIV Trial)): a study protocol for a randomised phase III trial
por: Coulson, Amy Beth, et al.
Publicado: (2022) -
Adaptation of the PERCEPT myeloma prehabilitation trial to virtual delivery: changes in response to the COVID-19 pandemic
por: McCourt, Orla, et al.
Publicado: (2022)